Moody Aldrich Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-20,119
| Closed | -$1.13M | – | 167 |
|
|
2022
Q3 | $1.13M | Buy |
+20,119
| New | +$1.13M | 0.23% | 111 |
|
|
2022
Q2 | – | Sell |
-33,358
| Closed | -$2.42M | – | 163 |
|
|
2022
Q1 | $2.42M | Buy |
33,358
+3,700
| +12% | +$269K | 0.34% | 77 |
|
|
2021
Q4 | $3.51M | Sell |
29,658
-5,342
| -15% | -$632K | 0.49% | 76 |
|
|
2021
Q3 | $4.7M | Buy |
35,000
+4,809
| +16% | +$645K | 0.6% | 72 |
|
|
2021
Q2 | $4.89M | Buy |
+30,191
| New | +$4.89M | 0.69% | 68 |
|